Analysis of the Status, Treatment & Outcomes of Rib Fractures

Status Completed

Clinical Trial Summary

A retrospective analysis of all patient presenting with multiple rib fractures to the emergency room of Penn State Hershey Medical Center between 2010-2012. Patient demographics, cause of fracture, outcomes, chronic medical conditions, vital signs, length of stay, pain levels and treatment, and sequelae will be recorded and analyzed.

Clinical Trial Description

This is a retrospective chart review with follow-up phone calls.

The initial part of the study will be a retrospective chart review. For this chart review study, the following data elements will be entered for each participant.

The investigators will perform a retrospective study of patients who have been treated for rib fractures at Penn State Hershey Medical Center (PSHMC). The time period of review will be 1/10/10 - 1/10/12 until 1500 cases have been reviewed. Data collected will be:

- Patient Medical Record Number (MRN)

- Name

- Phone number

- length of stay (admit and discharge date)

- Number of rib fractures per patient

- Cause of rib fracture

- Characteristics of the fracture (unilateral versus bilateral and multiple versus single)

- Pain management used for the rib fracture including pain interventions, medications and all pain scores

- Complications attributable to the rib fracture, including:

1. Shortness of Breath (SOB)

2. Hemothorax,

3. Pneumothorax

4. Flail chest

5. Intubation required

6. Mechanical ventilation required

7. Opioids required for pain

8. Chest tube placement required

- Sequelae of rib fracture, including:

1. Acute Respiratory Deficiency Syndrome (ARDS)

2. Pneumonia

3. Death

4. chronic pain

5. delayed subclavian vessel thrombosis

6. aortic aneurysm

7. tracheobronchial fistula

8. thoracic outlet syndrome

9. Horner's syndrome

- Clinical history of

1. Rib fractures

2. Other fractures

3. Osteoporosis

4. Chronic Obstructive Pulmonary Disease (COPD)

5. Cancer

6. Myocardial Infarction (MI) / Coronary Artery Disease (CAD)

7. Arthritis

8. Parkinson's disease

- Patient characteristics:

1. Age

2. Gender

3. Race

4. Body Mass Index (BMI)

5. Alcohol use

6. Smoking status

7. Marital status

8. Education

9. Initial blood pressure

7.2.2 Follow-up phone calls

The investigators will then attempt to call the patients for follow-up information using a summary explanation of research phone script to obtain the following information:

1. pain score

2. quality of life via the EuroQol's quality of life survey :EQ-5D-3L questionnaire

3. pain meds ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02487264
Study type	Observational
Source	Milton S. Hershey Medical Center
Contact
Status	Completed
Phase
Start date	June 2013
Completion date	December 14, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04848376` - Post-Market Clinical Follow-up Study of A-SPINE's Products
Terminated	`NCT03781817` - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures	Phase 4
Completed	`NCT04342416` - Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women	N/A
Recruiting	`NCT04856449` - DBT Skills Plus EMDR for BPD and Trauma	N/A
Completed	`NCT04356963` - Adjunct VR Pain Management in Acute Brain Injury	N/A
Completed	`NCT05669313` - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Active, not recruiting	`NCT03622632` - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Recruiting	`NCT04725721` - Testing FIRST in Youth Outpatient Psychotherapy	N/A
Active, not recruiting	`NCT05530642` - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel	N/A
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Not yet recruiting	`NCT03696563` - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS	N/A
Withdrawn	`NCT03249129` - Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Completed	`NCT02240732` - Surgical Tourniquets and Cerebral Emboli	N/A
Completed	`NCT02227979` - Effects of PURPLE Cry Intervention	N/A
Withdrawn	`NCT01169025` - Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients	N/A
Recruiting	`NCT01812941` - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients	N/A
Completed	`NCT01475344` - Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)	Phase 1/Phase 2
Completed	`NCT03112304` - Child STEPS for Youth Mental Health in Maine Sustainability	N/A
Completed	`NCT01201863` - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy	Phase 4
Completed	`NCT01210417` - Trauma Heart to Arm Time	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Analysis of the Status, Treatment and Outcomes of Rib Fractures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms